title: [Tardive dyskinesia].
abstract: Neuroleptic drug treatment can produce tardive dyskinesia of which the incidence, risk factors, clinical characteristics and problems of differential diagnosis are described. Possible therapeutic approaches are then considered in the light of the hypothesis that the condition may derive from a physiopathological hypersensitivity of the dopamine receptors.
authors.forename: F
authors.initials: F
authors.lastname: Sabbatini
authors.forename: S
authors.initials: S
authors.lastname: Gentile
authors.forename: M
authors.initials: M
authors.lastname: De Mattei
authors.forename: L
authors.initials: L
authors.lastname: Pinessi
authors.forename: I
authors.initials: I
authors.lastname: Rainero
mesh_terms: D014150:Antipsychotic Agents / Q000009:adverse effects*; D002819:Chorea / Q000175:diagnosis; D003937:Diagnosis, Differential; D004409:Dyskinesia, Drug-Induced / Q000175:diagnosis / Q000453:epidemiology / Q000209:etiology* / Q000517:prevention & control; D004421:Dystonia / Q000175:diagnosis; D006801:Humans; D007558:Italy; D010300:Parkinson Disease / Q000175:diagnosis; D011954:Receptors, Dopamine / Q000187:drug effects; D012306:Risk; D013565:Sympatholytics / Q000009:adverse effects; D013981:Tic Disorders / Q000175:diagnosis
chemical_list: D014150:Antipsychotic Agents; D011954:Receptors, Dopamine; D013565:Sympatholytics
vernacular_title: La discinesia tardiva.